Obesity White Papers & Case Studies

  1. Digital Twins: From Protocol Design to Predictive Study Execution 9/14/2026

    A growing generation of AI-enabled digital twin approaches offers a new path. Instead of treating the protocol as a static document, organizations can model it as a dynamic system.

  2. Accelerating Chronic Disease Clinical Study Reports With AI-Enabled Medical Writing And Expert Oversight 9/14/2026

    AI-enabled medical writing can cut clinical study report timelines by up to 70%, helping teams manage growing chronic disease trial documentation without sacrificing quality or oversight.

  3. Executing A Complex Global Breast Cancer Trial In A Rapidly Evolving Treatment Landscape 9/14/2026

    See how rapid site activation, strong oncology site relationships, and adaptive protocol management kept a complex global cancer trial on track amid evolving standards of care.

  4. How Sponsors Are Responding To FDA's RTCT Request For Information 9/9/2026

    Let's take a look at where continuous, real-time regulatory review can meaningfully speed drug development, and where it likely won't help much.

  5. Developing Next-Generation Therapies For Breast Cancer Patients 9/8/2026

    Breast cancer trials span multiple subtypes and modalities. Learn how specialized oncology experience helps reduce enrollment risk and keep programs on track.

  6. Beyond A Single Disease: Traversing Complexity In Breast Cancer Clinical Development 9/8/2026

    Biomarkers, new therapies, and tough enrollment hurdles are reshaping breast cancer trials. Get the insights to plan smarter.

  7. Cross-Functional Best Practices For Signal Detection In Special Case Scenarios 9/7/2026

    When trial data fall short, real risk signals surface in inquiries, complaints, and reports. Learn how coordinated, cross-functional practices help catch risk earlier.

  8. Trust In AI Agents Has To Be Earned Continuously, Not Just Once 9/7/2026

    This white paper lays out how ongoing performance monitoring, version control, and audit-ready traceability keep agentic AI trustworthy in a regulated environment.

  9. Stabilizing A Biotech Sponsor's Data Management And Biostatistics Functions 8/29/2026

    Discover how a rapid mid-study data transition rescued an endangered clinical trial, cleaned up compromised data, and secured a critical interim database lock within twelve months.

  10. Psychedelic Drug Trials: Are Your Sites Ready? 8/24/2026

    Psychedelic trials require unique operational approaches. Learn how to address patient safety, blinding, specialized assessments, and therapeutic setting considerations.